041910 — Polaris AI Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Polaris AI Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	52,123	50,991	30,590	27,454	46,691
Net Total Accounts Receivable
Net Total Receivables	12,650	15,444	14,837	16,273	14,317
Total Inventory
Prepaid Expenses
Total Current Assets	81,175	84,164	67,731	64,342	78,217
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31,952	31,306	31,138	30,592	30,007
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	129,221	134,361	124,319	121,899	134,451
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,166	9,037	7,036	4,871	4,717
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	13,052	11,062	8,230	6,266	5,868
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	116,169	123,299	116,089	115,633	128,583
Total Liabilities & Shareholders' Equity	129,221	134,361	124,319	121,899	134,451
Total Common Shares Outstanding